Liu Y - Search Results

1

High expression of CD147 and MMP-9 is correlated with poor prognosis of triple-negative breast cancer (TNBC) patients.

Zhao S, Ma W, Zhang M, Tang D, Shi Q, Xu S, Zhang X, Liu Y, Song Y, Liu L, Zhang Q. Zhao S, et al. Among authors: liu y, liu l. Med Oncol. 2013 Mar;30(1):335. doi: 10.1007/s12032-012-0335-4. Epub 2012 Dec 22. Med Oncol. 2013. PMID: 23263825 Free PMC article.

2

The prognostic role of circulating tumor cells (CTCs) detected by RT-PCR in breast cancer: a meta-analysis of published literature.

Zhao S, Liu Y, Zhang Q, Li H, Zhang M, Ma W, Zhao W, Wang J, Yang M. Zhao S, et al. Among authors: liu y. Breast Cancer Res Treat. 2011 Dec;130(3):809-16. doi: 10.1007/s10549-011-1379-4. Epub 2011 Feb 11. Breast Cancer Res Treat. 2011. PMID: 21311967

3

Bisphosphonate use and the risk of breast cancer: a meta-analysis of published literature.

Liu Y, Zhao S, Chen W, Hu F, Zhu L, Zhang Q, Zhao Y. Liu Y, et al. Clin Breast Cancer. 2012 Aug;12(4):276-81. doi: 10.1016/j.clbc.2012.04.003. Epub 2012 May 22. Clin Breast Cancer. 2012. PMID: 22622199 Review.

4

Circulating tumor cells (CTCs) detected by triple-marker EpCAM, CK19, and hMAM RT-PCR and their relation to clinical outcome in metastatic breast cancer patients.

Zhao S, Yang H, Zhang M, Zhang D, Liu Y, Liu Y, Song Y, Zhang X, Li H, Ma W, Zhang Q. Zhao S, et al. Among authors: liu y. Cell Biochem Biophys. 2013 Mar;65(2):263-73. doi: 10.1007/s12013-012-9426-2. Cell Biochem Biophys. 2013. PMID: 22990361

5

Bisphosphonate and risk of cancer recurrence: protocol for a systematic review, meta-analysis and trial sequential analysis of randomised controlled trials.

Liu Y, Du C, Zhang Y, Zhao S, Zhao L, Li P, Hu F, Zhu L, Liu Y, Pang D, Zhao Y. Liu Y, et al. BMJ Open. 2015 Apr 21;5(4):e007215. doi: 10.1136/bmjopen-2014-007215. BMJ Open. 2015. PMID: 25900461 Free PMC article.

6

The Expression of CD9 and PIK3CD is Associated with Prognosis of Follicular Lymphoma.

Dong T, Liu Z, Zhao S, Hu C, Liu Y, Ma W, Zhang Q. Dong T, et al. Among authors: liu z, liu y. J Cancer. 2015 Oct 15;6(12):1222-9. doi: 10.7150/jca.11279. eCollection 2015. J Cancer. 2015. PMID: 26535063 Free PMC article.

7

DUSP1 promoter methylation in peripheral blood leukocyte is associated with triple-negative breast cancer risk.

Li J, Chen Y, Yu H, Tian J, Yuan F, Fan J, Liu Y, Zhu L, Wang F, Zhao Y, Pang D. Li J, et al. Among authors: liu y. Sci Rep. 2017 Feb 21;7:43011. doi: 10.1038/srep43011. Sci Rep. 2017. PMID: 28220843 Free PMC article.

8

The prognostic value of programmed cell death ligand 1 expression in non-Hodgkin lymphoma: a meta-analysis.

Zhao S, Zhang M, Zhang Y, Meng H, Wang Y, Liu Y, Jing J, Huang L, Sun M, Zhang Y, Zhang Q. Zhao S, et al. Among authors: liu y. Cancer Biol Med. 2018 Aug;15(3):290-298. doi: 10.20892/j.issn.2095-3941.2018.0047. Cancer Biol Med. 2018. PMID: 30197796 Free PMC article.

9

The prognostic value of toll-like receptor5 and programmed cell death-ligand1 in patients with peripheral T-cell non-Hodgkin lymphoma.

Sun M, Su W, Qian J, Meng H, Ji H, Liu Y, Zhang Y, Li W, Zhang Q, Zhao S. Sun M, et al. Among authors: liu y. Leuk Lymphoma. 2019 Nov;60(11):2646-2657. doi: 10.1080/10428194.2019.1602266. Epub 2019 Apr 24. Leuk Lymphoma. 2019. PMID: 31017033

10

TLR4 expression correlated with PD-L1 expression indicates a poor prognosis in patients with peripheral T-cell lymphomas.

Zhao S, Sun M, Meng H, Ji H, Liu Y, Zhang M, Li H, Li P, Zhang Y, Zhang Q. Zhao S, et al. Among authors: liu y. Cancer Manag Res. 2019 May 23;11:4743-4756. doi: 10.2147/CMAR.S203156. eCollection 2019. Cancer Manag Res. 2019. PMID: 31191027 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

208,041 results

Search Page

Filters